Drug intelligence / Profile preview

xenon + oxygen

Development stage
Unknown
Lead developer
Invero Pharma
Modality
Small Molecules
Administration
Inhalation
01

Overview

Xenon + oxygen is a combination of the noble gas xenon and molecular oxygen, administered as an inhaled gas mixture. Xenon acts primarily as a general anesthetic and neuroprotective agent, while oxygen ensures adequate tissue oxygenation during administration. Xenon's mechanism of action includes antagonism at the N-methyl-D-aspartate (NMDA) receptor, contributing to its anesthetic and neuroprotective effects. The combination is used in anesthesia (notably in Europe), for diagnostic imaging (such as lung ventilation studies with hyperpolarized xenon isotopes), and is under investigation for neuroprotection after hypoxic injury, treatment-resistant depression, anxiety disorders, obsessive-compulsive disorder (OCD), and potentially Alzheimer's disease. The mixture offers rapid onset/offset of action with minimal cardiovascular side effects compared to other inhalational agents[5][7][9]. Research continues into its psychiatric applications and brain protection properties.

Other names
xenon + oxygen氙气 + 氧气
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on xenon + oxygen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xenon + oxygen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call